Achieve Life Sciences share price logo

Achieve Life Sciences

NASDAQ: ACHV

Small Cap

$6.38

-0.59

(-8.46%)

as on

Achieve Life Sciences Stock Performance

as on October 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $6.22
    $7.02
    downward going graph

    2.51%

    Downside

    10.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.62
    $8.64
    downward going graph

    58.93%

    Downside

    35.42%

    Upside

    downward going graph

Achieve Life Sciences share price movements today

Previous Close
$6.97
Open
$6.93
Volume
2.0M
Market Cap
$718.6M
Day's Low - High
$6.22 - $7.02
52 Week Low - High
$2.62 - $8.64

Achieve Life Sciences Historical Returns

1 Month Return
-19.34 %
3 Month Return
+ 1.75 %
1 Year Return
+ 51.9 %
3 Year Return
+ 64.01 %
5 Year Return
-20.75 %

Achieve Life Sciences Stock Fundamentals & Key Indicators

Check Achieve Life Sciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$718.6M

EPS (TTM)

-1.55

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.5

Industry PE ratio

-6.86

PEG Ratio

0.21

EBITDA

-112.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-892.07%

Achieve Life Sciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Achieve Life Sciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$718.6M-20.75%-4.500.00%0.00%
Neutral$94.4B-32.76%-29.64-12.57%0.00%
StrongBuy$128.9B174.93%29.3786.04%0.00%
Buy$80.1B42.93%19.0184.86%0.46%

Stock Returns calculator for Achieve Life Sciences Stock including INR - Dollar returns

The Achieve Life Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Achieve Life Sciences investment value today

Current value as on today

₹1,63,914

Returns

₹63,914

(+63.91%)

Returns from Achieve Life Sciences Stock

₹51,905 (+51.9%)

Dollar Impact

₹12,010 (+12.01%)

Analyst Recommendation on Achieve Life Sciences Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Achieve Life Sciences. Average target price of $14.15

Achieve Life Sciences Share Price Target

Get share price movements and forecasts by analysts on Achieve Life Sciences.

What analysts predicted

54.91%UPSIDE

Target Price

$14.15

Current Price

$6.38

Analyzed by

2 Analysts

High

$17

Target

$14.15

Low

$13

Achieve Life Sciences target price $14.15, a slight upside of 54.91% compared to current price of $6.38. According to 2 analysts rating.

Indian Investors' Interest in Achieve Life Sciences Stock

Search interest for Achieve Life Sciences Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-12% versus previous 30 day period

Achieve Life Sciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
0
0
0
-
0
-
Operating Income
-5
-8
-
-12
-12
-12
-14
-14
-10
-18
EBITDA
-5
-7
-12
-12
-12
-12
-14
-14
-9
-74
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-6
-8
-12
-12
-12
-12
-14
-14
-10
-74
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-6
-8
-12
-12
-12
-12
-14
-14
-10
-74
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Achieve Life Sciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
-
0
0
Operating Income
-6
-12
-16
-14
-33
-40
-27
-39
-54
EBITDA
-13
-12
-16
-14
-32
-40
-26
-37
-53
Interest Expense
-
-
-
-
-
1
2
2
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-12
-16
-14
-33
-42
-29
-39
-54
Income Tax Expense
-3
-
-
-
-
-
-
-
-
Net Income
-10
-12
-16
-14
-33
-42
-29
-39
-54
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Achieve Life Sciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-6
-8
-12
-12
-12
-12
-14
-14
-10
-74
Operating Cash Flow
-5
-4
-10
-9
-11
-9
-11
-17
-6
-10
Investing Cash Flow
-
-46
13
11
11
6
-12
0
14
-137
Financing Cash Flow
56
0
-8
0
-
41
4
6
0
168
Change in Cash
50
-51
-5
3
0
38
-19
-11
7
19

Achieve Life Sciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-10
-12
-16
-14
-33
-42
-29
-39
-54
Operating Cash Flow
-9
-10
-15
-13
-29
-37
-24
-29
-49
Investing Cash Flow
12
-5
5
0
-
-
0
-21
6
Financing Cash Flow
2
19
17
32
36
19
15
48
51
Change in Cash
5
4
7
19
7
-18
-9
-2
8

Global Institutional Holdings in Achieve Life Sciences

Check out the Institutions with significant holdings in Achieve Life Sciences.

Funds
Holdings
Vanguard
4.67%
iShares
3.08%
SPDR
2.36%
VANGUARD INDEX FUNDS
2.09%
Franklin Strategic Series
1.53%

Achieve Life Sciences News & Key Events

  • img

    Today's Timeline - 01 October

    Fri, 02:49 AM

    -

    Achieve Life Sciences appoints Benjamin Halladay as CFO, effective October 5, 2026, succeeding Mark Oki.

Insights on Achieve Life Sciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 686.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 152.5% return, outperforming this stock by 88.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ACHV stock has moved down by -13.9%

About Achieve Life Sciences

Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
OrganisationAchieve Life Sciences
Headquarters22722 29th Dr. SE, Bothell, WA, 98021, US
IndustryBiotechnology
CEOAndrew D. Goldberg

Key Management of Achieve Life Sciences

Name

Title

Mr. Erik Atkisson

Chief Legal Officer

Mr. Mark Zappia

Senior Vice President of Commercial

Mr. Ronald Dadino

Senior Vice President of Chemistry, Manufacturing & Controls and Supply Chain

Dr. Andrew D. Goldberg M.D.

CEO, President & Director

Mr. Benjamin Halladay M.B.A.

Chief Financial Officer

Mr. Jerry Wan

VP of Finance & Principal Accounting Officer

Ms. Kaitlyn Tuson

Senior Vice President of Marketing & Communications

Dr. Mark L. Rubinstein M.D.

Chief Medical Officer

Ms. Gloria Cosgrove

Senior Vice President of Global Quality

Ms. Nicole P. Jones

Vice President of Strategic Communications & Stakeholder Relations

FAQs

What is Achieve Life Sciences share price today?

Achieve Life Sciences share price today is $6.38 as on at the close of the market. Achieve Life Sciences share today touched a day high of $7.02 and a low of $6.22.

What is the 52 week high and 52 week low for Achieve Life Sciences share?

Achieve Life Sciences share touched a 52 week high of $8.64 on and a 52 week low of $2.62 on . Achieve Life Sciences stock price today i.e. is closed at $6.38,which is 26.16% down from its 52 week high and 143.51% up from its 52 week low.

What is Achieve Life Sciences's market capitalisation today?

Achieve Life Sciences market capitalisation is $0.00T as on .

How to invest in Achieve Life Sciences Stock (ACHV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Achieve Life Sciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Achieve Life Sciences Stock (ACHV) from India?

Indian investors can start investing in Achieve Life Sciences (ACHV) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Achieve Life Sciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Achieve Life Sciences share’s latest price of $6.38 as on October 17, 2026 at 8:45 am IST, you will get 1.5674 shares of Achieve Life Sciences. Learn more about fractional shares .

What are the returns that Achieve Life Sciences has given to Indian investors in the last 5 years?

Achieve Life Sciences stock has given -20.75% share price returns and 26.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?